I hear from patients with serious life-threatening conditions, constituents in north Texas, being frustrated with what they see as a regulatory barrier from trying and experimenting with new therapies when all others have failed them.
Burgess addresses patient frustrations over regulatory barriers to accessing new therapies.
Share
More from Michael Burgess
For the purpose of debate only, I yield the customary 30 minutes to the gentleman from Massachusetts (Mr. McGovern), pending which I yield myself such time as I may consume. During consideration of this resolution, all time yielded is for…
By direction of the Committee on Rules, I call up House Resolution 1568 and ask for its immediate consideration. The Clerk read the resolution, as follows: H. Res. 1568 Resolved, That upon adoption of this resolution it shall be in order…
I reserve the balance of my time. Mr. McGOVERN. Mr. Speaker, I yield 4 minutes to the gentlewoman from New Mexico (Ms. Leger Fernandez), a distinguished member of the Rules Committee.
By direction of the Committee on Rules, I call up House Resolution 1616 and ask for its immediate consideration. The Clerk read the resolution, as follows: H. Res. 1616 Resolved, That upon adoption of this resolution it shall be in order…
Other voices in this conversation
